KAHAARI KENYATTA — Lobbyist Profile | Poliscope

KAHAARI KENYATTA

Filings

Clients

Firms

Years active

2021–2023

Associated filing income

$841,522

How to read the money

Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.

Clients represented

Client	Filings	Years
CAMPAIGN FOR TOBACCO FREE KIDS	10	2021–2023
MEDICINES360	10	2021–2023
GARY AND MARY WEST HEALTH INSTITUTE, INC	6	2022–2023

Lobbying firms

Firm	Filings	Years
WAXMAN STRATEGIES	26	2021–2023

Bills explicitly cited in this lobbyist’s assigned issues (7)

No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.

S. 2257

Expanding Access to Affordable Prescription Drugs and Medical Devices Act

Client: MEDICINES360 · Firm: WAXMAN STRATEGIES

Open original LDA filing ↗

Cited source text

Support for non-profit pharmaceutical manufacturers, S. 2257

S. 2257

Expanding Access to Affordable Prescription Drugs and Medical Devices Act

Client: MEDICINES360 · Firm: WAXMAN STRATEGIES

Open original LDA filing ↗

Cited source text

Support for non-profit pharmaceutical manufacturers, S. 2257

Original LDA source filings (26)

Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.

CAMPAIGN FOR TOBACCO FREE KIDS via WAXMAN STRATEGIES

2023 · third_quarter · Q3

Firm income: $60,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TOB

Tobacco

Issues related to tobacco, e-cigarettes and public health.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

CAMPAIGN FOR TOBACCO FREE KIDS via WAXMAN STRATEGIES

2023 · second_quarter · Q2

Firm income: $60,000Client expense: —Open original LDA filing ↗

Source: Senate LDA

Show 22 more original filings

CAMPAIGN FOR TOBACCO FREE KIDS via WAXMAN STRATEGIES

2023 · first_quarter · Q1

Firm income: $60,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TOB

Tobacco

Issues related to tobacco, e-cigarettes and public health.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

MEDICINES360 via WAXMAN STRATEGIES

2023 · first_quarter · Q1

Firm income: $16,560Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Support for non-profit pharmaceutical manufacturers

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

GARY AND MARY WEST HEALTH INSTITUTE, INC via WAXMAN STRATEGIES

2023 · first_quarter · Q1

Firm income: $25,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Issues impacting drug prices and health care costs

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

CAMPAIGN FOR TOBACCO FREE KIDS via WAXMAN STRATEGIES

2022 · fourth_quarter · Q4

Firm income: $60,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TOB

Tobacco

Issues related to tobacco, e-cigarettes and public health.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

MEDICINES360 via WAXMAN STRATEGIES

2022 · fourth_quarter · Q4

Firm income: $7,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Support for non-profit pharmaceutical manufacturers, S. 2257

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

GARY AND MARY WEST HEALTH INSTITUTE, INC via WAXMAN STRATEGIES

2022 · fourth_quarter · Q4

Firm income: $25,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Issues impacting drug prices

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

CAMPAIGN FOR TOBACCO FREE KIDS via WAXMAN STRATEGIES

2022 · third_quarter · Q3

Firm income: $60,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TOB

Tobacco

Issues related to tobacco, e-cigarettes and public health.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

MEDICINES360 via WAXMAN STRATEGIES

2022 · third_quarter · Q3

Firm income: $7,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Support for non-profit pharmaceutical manufacturers, S. 2257

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

GARY AND MARY WEST HEALTH INSTITUTE, INC via WAXMAN STRATEGIES

2022 · third_quarter · Q3

Firm income: $25,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Issues impacting drug prices

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

CAMPAIGN FOR TOBACCO FREE KIDS via WAXMAN STRATEGIES

2022 · second_quarter · Q2

Firm income: $60,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TOB

Tobacco

Issues related to tobacco, e-cigarettes and public health.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

MEDICINES360 via WAXMAN STRATEGIES

2022 · second_quarter · Q2

Firm income: $9,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Support for non-profit pharmaceutical manufacturers, S. 2257

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

GARY AND MARY WEST HEALTH INSTITUTE, INC via WAXMAN STRATEGIES

2022 · second_quarter · Q2

Firm income: $25,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Issues impacting drug prices

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

CAMPAIGN FOR TOBACCO FREE KIDS via WAXMAN STRATEGIES

2022 · first_quarter · Q1

Firm income: $60,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TOB

Tobacco

Issues related to tobacco, e-cigarettes and public health.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

MEDICINES360 via WAXMAN STRATEGIES

2022 · first_quarter · Q1

Firm income: $5,250Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Support for non-profit pharmaceutical manufacturers, S. 2257

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

GARY AND MARY WEST HEALTH INSTITUTE, INC via WAXMAN STRATEGIES

2022 · first_quarter · Q1

Firm income: $25,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Issues impacting drug prices

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

CAMPAIGN FOR TOBACCO FREE KIDS via WAXMAN STRATEGIES

2021 · fourth_quarter · Q4

Firm income: $60,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TOB

Tobacco

Issues related to tobacco, e-cigarettes and public health.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

MEDICINES360 via WAXMAN STRATEGIES

2021 · fourth_quarter · Q4

Firm income: $5,250Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Support for non-profit pharmaceutical manufacturers, S. 2257

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

CAMPAIGN FOR TOBACCO FREE KIDS via WAXMAN STRATEGIES

2021 · third_quarter · Q3

Firm income: $60,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TOB

Tobacco

Issues related to tobacco, e-cigarettes and public health.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

MEDICINES360 via WAXMAN STRATEGIES

2021 · third_quarter · Q3

Firm income: $11,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Support for non-profit pharmaceutical manufacturers, S. 2257

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

MEDICINES360 via WAXMAN STRATEGIES

2021 · second_quarter · Q2

Firm income: $9,600Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Support for non-profit pharmaceutical manufacturers, S. 2257

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

CAMPAIGN FOR TOBACCO FREE KIDS via WAXMAN STRATEGIES

2021 · first_quarter · 1A

Firm income: $60,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TOB

Tobacco

Issues related to tobacco, e-cigarettes and public health.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

MEDICINES360 via WAXMAN STRATEGIES

2021 · first_quarter · Q1

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Support for non-profit pharmaceutical manufacturers

Filing targets: SENATE